Filing Details

Accession Number:
0001181431-13-049802
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-18 19:02:01
Reporting Period:
2013-09-16
Filing Date:
2013-09-18
Accepted Time:
2013-09-18 19:02:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191285 D Virgil Thompson 1300 North Kellogg Drive
Suite D
Anaheim CA 92807
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-16 5,000 $4.50 34,867 No 4 M Direct
Common Stock Disposition 2013-09-16 5,000 $63.75 29,867 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-09-16 5,000 $0.00 5,000 $4.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,500 2018-02-27 No 4 M Direct
Footnotes
  1. Non-qualified stock options were granted under the Company's 2006 Equity Incentive Award Plan.
  2. The option was granted on 02/29/2008 for the right to buy 7,500 shares of common stock of the Issuer. The options vested 100% on the date of grant.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.6201-$63.8601. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.